How to diagnose cardiac amyloidosis early: Impact of ECG, tissue Doppler echocardiography, and myocardial biopsy

Amyloid

Volumn 17, Issue 1, 2010, Pages 1-9

  Piper, Cornelia ^a   Butz, Thomas ^a,b   Farr, Martin ^a   Faber, Lothar ^a   Oldenburg, Olaf ^a   Horstkotte, Dieter ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Cardiac amyloidosis; Low voltage; Myocardial biopsy; Restrictive cardiomyopathy; Tissue Doppler echocardiography; Two dimensional strain

Indexed keywords

AMYLOID; AMYLOID KAPPA PROTEIN; AMYLOID LAMBDA PROTEIN; MELPHALAN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BIREFRINGENCE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONSTRICTIVE PERICARDITIS; DIAGNOSTIC ACCURACY; DRUG MEGADOSE; EARLY DIAGNOSIS; ELECTROCARDIOGRAM; FEMALE; GENETIC ANALYSIS; HEART AMYLOIDOSIS; HEART FAILURE; HEART INFARCTION; HEART MUSCLE BIOPSY; HEART RIGHT VENTRICLE DYSPLASIA; HEART TRANSPLANTATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMMUNOHISTOCHEMISTRY; MALE; PERICARDIAL EFFUSION; PRIORITY JOURNAL; R WAVE; RESTRICTIVE CARDIOMYOPATHY; TISSUE DOPPLER IMAGING;

AGED; AGED, 80 AND OVER; AMYLOID; AMYLOIDOSIS; BIOPSY; CARDIOMYOPATHIES; COHORT STUDIES; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; TIME FACTORS;

EID: 77149167607     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506121003619310     Document Type: Article

References (39)

1. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med 1997;337:898-909.
2. Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med 2003;349:583-596.
3. Bird J for the UK Myeloma Forum AL amyloidosis Guidelines Working Group. Guidelines on the diagnosis and management of AL amyloidosis. United Kingdom Myeloma Forum 2004;125:681-700.
4. Dubrey SM, Cha K, Anderson J, Charmarthi B, Reisinger J, Skinner M, Falk RH. The clinical features of immunoglobin light-chain (AL) amyloidosis with heart involvement. Q J Med 1998;91:141-157.
5. Dubrey SW, Cha K, Simms RW, Skinner M, Falk RH. Electrocardiography and Doppler echocardiography in secondary (AA) amyloidosis. Am J Cardiol 1996;77:313-315.
6. Tanaka F, Migita K, Honda S, Fukuda T, Mine M, Nakamura T, Yamasaki S, Ida H, Kawakami A, Origuchi T, Eguchi K. Clinical outcome and survival of secondary (AA) amyloidosis. Clin Exp Rheumatol 2003;21:343-346.
7. Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation 2005;112:2047-2060.
8. Kyle RA, Gertz MA, Greipp PhR, Witzig ThE, Lust JA, Lacy MQ, Therneau TM. Long-term survival (10 years or more) in 30 patients with primary amyloidosis. Blood 1999;3:1062-1066.
9. Selvanayagam JB, Hawkins PN, Paul B, Myerson SG, Neubauer S. Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol 2007;50:2101-2110.
10. Hamer JP, Janssen S, van Rijswijk MH, Lie KI. Amyloid cardiomyopathy in systemic non-hererditary amyloidosis. Clinical, echocardiographic and electrocardiographic findings in 30 patients with AA and 24 patients with AL amyloidosis. Eur Heart J 1992;13:623-627.
11. Murtagh B, Hammill StC, Gertz AM, Kyle RA, Tajik AJ, Grogan M. Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol 2005;95:535-537.
12. Koyama J, Ray-Sequin PA, Davidoff R, Falk RH. Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis. Am J Cardiol 2002;89:1067-1071.
13. Koyama J, Davidoff R, Falk RH. Longitudinal myocardial velocity gradient derived from pulsed Doppler tissue imaging in AL amyloidosis: a sensitive indicator of systolic and diastolic dysfunction. J Am Soc Echocardiography 2004; 17:36-44.
14. Koyama J, Ray-Sequin PA, Falk RH. Longitudinal myocardial function assessed by tissue velocity, strain and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation 2003;107:2446-2452.
15. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, Tajik AJ. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures. A comparative simultaneous Doppler-catheterization study. Circulation 2000;102:1788-1794.
16. Kasner M, Westermann D, Steendijk P, Gaub R, Wilkenshoff U, Weitmann K, Hoffmann W, Poller W, Schultheiss HP, Pauschinger M, et al. Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction. A comparative Doppler-conductance catheterization study. Circulation 2007;116:637-647.
17. Paulus W, Tschöpe C, Sanders JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of European Society of Cardiology. Eur Heart J 2007;28:2539-2550. (Pubitemid 47614269)
18. Sallach JA, Klein AL. Tissue Doppler imaging in the evaluation of patients with cardiac amyloidosis. Curr Opin Cardiol 2004;19:464-471.
19. Flachskampf FA, Breithardt OA, Daniel WG. Diagnostic value of tissue Doppler parameters in the early diagnosis of cardiomyopathies. Herz 2007;32:89-96.
20. Weidemann F, Strotmann JM. Use of tissue Doppler imaging to identify and manage systemic diseases. Clin Res Cardiol 2008;97:65-73.
21. Cheitlin MD, Alpert JS, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davidson TW, Davis JL, Douglas PS, Gillam LD. ACC/AHA Guidelines for the Clinical Application of Echocardiography. Circulation 1997;95: 1686-1744
22. Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, Douglas PS, Faxon DP, Gillam LD, Kimball TR, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/ AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation 2003;108:1146-1162.
23. Gottdiener JS, Bednarz J, Devereux R, Gardin J, Klein A, Manning WJ, Morehead A, Kitzman D, Oh J, Quinones M, et al. American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr 2004;17:1086-1119.
24. Douglas PS, Khandheria B, Stainback RF, Weissman NJ, Brindis RG, Patel MR, Khandheria B, Alpert JS, Fitzgerald D, Heidenreich P, et al. ACCF/ASE/ACEP/ASNC/SCAI/ SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American Society of Echocardiography, American College of Emergency Physicians, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society for Cardiovascular Magnetic Resonance endorsed by the American College of Chest Physicians and the Society of Critical Care Medicine. J Am Coll Cardiol 2007;50:187-204.
25. Ommen, S. Echocardiographic assessment of diastolic function. Curr Op Cardiol 2001;16:240-245.
26. Garcia MJ, Rodriguez L, Ares M, Griffin BP, Thomas JD, Klein AL. Differentiation of constrictive pericarditis from restrictive cardiomyopathy: assessment of left ventricular diastolic velocities in longitudinal axis by Doppler Tissue Imaging. J Am Coll Cardiol 1996;27:108-114.
27. Butz T, Faber L, Piper C, Langer C, Kottmann T, Schmidt HK, Wiemer M, Kö rfer R, Horstkotte D. Tissue Doppler imaging in the differential diagnosis of constrictive pericarditis and restrictive cardiomyopathy. Dtsch Med Wochenschr 2008;133:399-405.
28. Rajagopalan N, Garcia MJ, Rodriguez L, Murray RD, Apperson-Hansen C, Stugaard M, Thomas JD, Klein AL. Comparison of new Doppler echocardiographic methods to differentiate constrictive pericardial heart disease and restrictive cardiomyopathy. Am J Cardiol 2001;87:86-94.
29. Sengupta PP, Mohan JC, Mehta V, Arora R, Pandian NG, Kandheria BK. Accuracy and pitfalls of early diastolic motion of the mitral annulus for diagnosing constrictive pericarditis by tissue doppler imaging. Am J Cardiol 2004;93:886-890.
30. Ha JW, Ommen S, Tajik AJ, Barnes ME, Ammash NM, Gertz MA, Seward JB, Oh JK. Differentiation of constrictive pericarditis from restrictive cardiomyopathy using mitral annular velocity of tissue Doppler echocardiography. Am J Cardiol 2004;94:316-319.
31. Nagueh SF,McFalls J,Meyer D, Hill R, Zoghbi WA, Tam JW, Quiñones MA, Roberts R, Marian AJ. Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects withsubclinicaldisease.Circulation. 2003;108:395-398.
32. Serri K, Reant P, Lafitte M, Berhouet M, Le Bouffos V, Roudaut R, Lafitte S. Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathy. J Am Coll Cardiol 2006; 47:1175-1181.
33. Becker M, Hoffmann R, Kühl HP, Grawe H, Katoh M, Kramann R, Bücker A, Hanrath P, Heussen N. Analysis of myocardial deformation based on ultrasonic pixel tracking to determine transmurality in chronic myocardial infarction. Eur Heart J 2006;27:2560-2566.
34. Cueto-Gracia L, Reeder GS, Kyle RA, Wood DL, Seward JB, Naessens J, Offord KP, Greipp PR, Edwards WD, Tajik AJ. Echocardiographic findings in systemic amyloidosis spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol 1985;6:737-743.
35. Murtagh B, Hammill StC, Gertz MA, Kyle RA, Tajik AJ, Grogan M. Electrocardiograpic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol 2005;95:535-537.
36. Rahman JE, Helou EF, Gelzer-Bell R, Thompson E, Kuo C, Rodriguez ER, Hare JM, Baughman KL, Kasper EK. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol 2004;43:410-415.
37. Klein AL, Hatle LK, Taliercio ChP, Oh JK, Kyle RA, Gertz MA, Bailey KR, Seward JB, Tajik AJ. Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. Circulation 1991;83:808-816.
38. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, Levine GN, Narula J, Starling RC, Towbin J, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. Eur Heart J 2007;28:3076-3093. (Pubitemid 350262258)
39. Piper C, Horstkotte D. Endomyocardial biopsy [Editorial]. J Heart Valve Dis 2003;12:153-155.